IOmx Therapeutics AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.iomx.com
Clinical Trials
2
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Study of OMX-0407 in Patients With Previously Treated Solid Tumours That Can't be Removed Surgically
- First Posted Date
- 2023-04-24
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- iOmx Therapeutics AG
- Target Recruit Count
- 158
- Registration Number
- NCT05826600
- Locations
- 🇧🇪
Cliniques Universitaires Saint-Luc, Brussels, Belgium
🇧🇪Universitair Ziekenhuis Gent, Ghent, Belgium
🇧🇪CHU de Liège, Liège, Belgium
News
No news found